Search

Author/Creator Llorens, Lily

1. A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment. (April 2022)

Authors:
Cohen, Jeffrey A; Cameron, Michelle H; Goldman, Myla D; Goodman, Andrew D; Miller, Aaron E; Rollins, Anne; Llorens, Lily; Patni, Rajiv; Elfont, Robert; Johnson, Reed
Journal:
Multiple sclerosis
Issue:
Volume 28:Number 5(2022)
Page Start:
817
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials. (13th April 2016)

Authors:
Taboada, Maria; Melnick, David; Iaconis, Joseph P.; Sun, Fang; Zhong, Nan Shan; File, Thomas M.; Llorens, Lily; Friedland, H. David; Wilson, David
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 71:Number 6(2016:Jun.)
Page Start:
1748
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial. (April 2019)

Authors:
Cohen, Jeffrey A; Hunter, Samuel F; Brown, Theodore R; Gudesblatt, Mark; Thrower, Ben W; Llorens, Lily; Souza-Prien, Cindy J; Ruby, April E; Chernoff, David N; Patni, Rajiv
Journal:
Multiple sclerosis
Issue:
Volume 25:Number 4(2019)
Page Start:
601
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗